ACA App
Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia
Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Submission | Subscribe | Advertise | Contact | Login 
Users online: 593 Small font size Default font size Increase font size Print this article Email this article Bookmark this page
 


 

 
     
    Advanced search
 

 
 
     
  
    Similar in PUBMED
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed65    
    Printed2    
    Emailed0    
    PDF Downloaded4    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents
ERRATUM  
Year : 2020  |  Volume : 23  |  Issue : 4  |  Page : 545
Erratum: Intensive care and anesthesia management for HARPOON beating heart mitral valve repair



Click here for correspondence address and email

Date of Web Publication19-Oct-2020
 

How to cite this article:
. Erratum: Intensive care and anesthesia management for HARPOON beating heart mitral valve repair. Ann Card Anaesth 2020;23:545

How to cite this URL:
. Erratum: Intensive care and anesthesia management for HARPOON beating heart mitral valve repair. Ann Card Anaesth [serial online] 2020 [cited 2020 Nov 24];23:545. Available from: https://www.annals.in/text.asp?2020/23/4/545/298546




In the article titled “Intensive Care and Anesthesia Management for HARPOON Beating Heart Mitral Valve Repair”, published on pages 321-326, Issue 3, Volume 23 of Annals of Cardiac Anaesthesia,[1] the below statement was incorrectly written on page 321, 35th line of the last paragraph under Introduction heading:

”The early results of both an initial feasibility study [7] and a further trial toward gaining CE approval (the “Tracer Trial”),[8] have involved a total of 43 patients in six centers in Europe, with a reported procedural success rate of 95% (41 out of 43 patients), and of those patients with a HARPOON Beating Heart MVRS repair, freedom from moderate magnetic resonance (MR) or worse at 6 months of 89%.”

The correct statement should read as:

”The early results of both an initial feasibility study [7] and a further trial toward gaining CE approval (the “Tracer Trial”),[8] have involved a total of 41 patients in six centers in Europe, with a reported procedural success rate of 95% (39 out of 41 patients), and of those patients with a HARPOON Beating Heart MVRS repair, freedom from moderate mitral regurgitation (MR) or worse at 6 months of 83%..”



 
   References Top

1.
Diprose P, Fogg KJ, Pittarello D, Gammie JS, D'Ambra MN. Intensive care and anesthesia management for HARPOON beating heart mitral valve repair. Ann Card Anaesth 2020;23:321-6.  Back to cited text no. 1
[PUBMED]  [Full text]  

Top
Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.298546

Rights and Permissions




 

Top